Previous genetic studies have found typical mutations/aberrations in prostate cancer, including ERG gene fusions, p53 aberrations, Androgen Receptor (AR) amplifications, and Speckle type Poz Protein (SPOP) missense mutations (3). The gene discussed is AR; the disease is prostate carcinoma.